The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy
Crossref DOI link: https://doi.org/10.1038/bcj.2014.97
Published Online: 2015-01-30
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Buckley, S A
Othus, M
Estey, E H
Walter, R B
Text and Data Mining valid from 2015-01-30
Version of Record valid from 2015-01-30
Article History
First Online: 30 January 2015
Competing interests
: The authors declare no conflict of interest.